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Carcinogenicity and Toxicity of
Methoxychlor
by Melvin Dwaine Reuber*
Methoxychlor is carcinogenic for the liver of C3H and BALB/c mice and Osborne-Mendel
rats, and possibly for the liver of dogs. Methoxychlor is also carcinogenic for the testis of
BALB/c male mice, bone ofB6C3F1 female mice, and the ovary ofOsborne-Mendel female rats.
The incidences of carcinomas of the liver were increased in C3H male mice and BALB/c male
and female mice fed methoxychlor. There also was an increase in malignant neoplasms at all
sites in BALB/c male and female mice. C3H and BALB/c male mice were more susceptible to
the carcinogenic effects ofmethoxychlor than were female mice. BALB/c mice were more sus-
ceptible than C3H mice. Osborne-Mendel male and female rats developed significant incidences
of carcinomas of the liver. The incidence of sarcomas of the spleen and abdomen, mostly he-
mangiosarcomas, was increased in male rats. Neoplasms of the pituitary, adrenals, and mam-
mary gland were also increased in methoxychlor-treated female rats. Miniature swine given
methoxychlor developed chronic renal disease in relatively short periods oftime. There also was
hyperplasia of the mammary gland and uterus, suggesting an estrogen-like effect on those or-
gans. Methoxychlor applied to the skin ofrabbits caused a dose-related atrophy ofthe testes, as
well as chronic renal disease. Atrophy ofthe testes and chronic renal disease could not be eval-
uated in mice and rats because of insufficient data.
Introduction
Methoxychlor [1,1'- (2,2,2-trichloroethyli-
dene) bis (4-methoxy) benzene], also known as
dianisyltrichlorethane, dimethoxy DDT, and
DMDT, is a structural analog of DDT. It is used
against a wide range of insects that attack fruits,
vegetables, shade trees, home gardens, forage
crops, and livestock. Methoxychlor is also used for
the spray treatment of barns, grain storage bins,
mushroom houses, dairies, and other agricultural
buildings. Since methoxychlor is relatively inef-
fective against soil organisms, it is generally ap-
plied directly to crops by ground or aerial
spraying.
This review includes, to the best of our knowl-
edge, every study on the carcinogenicity of me-
thoxychlor in animals. The results and conclusions
are based upon my examination of the raw data
and, whenever possible, of the histological sec-
tions. The histological sections were examined for
the FDA Methoxychlor Mouse Study, FDA Me-
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thoxychlor Rat Study, FDA Methoxychlor Dog
Study, FDA Methoxychlor Swine Studies, FDA
Methoxychlor Rabbit Study, NCI Methoxychlor
Rat Study, and NCI Methoxychlor Mouse Study.
Other studies reviewed were by Hodge et al., Ra-
domsky et al., and Deichmann et al.
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FDA Methoxychlor Mouse Study
BALB/c (BALB/cJ) and C3H (C3HeB/FeJ)
strains male and female mice ingested 750 ppm
technical methoxychlor (1,2). Mice, 3 weeks of
age, were given the pesticide in ground labora-
tory meal for periods up to 2 years. There were
100 mice of each strain and sex given methoxy-
chlor, as well as 100 controls of each sex.
Tissues from all mice with lesions, as well as
tissues from many grossly normal mice, were
fixed in 10% formalin. Hematoxylin and eosin
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gross lesions in which tumors were suspected and
from tissues with incidental gross lesions. The
procedures have been described (3).
BALB/c male mice ingesting methoxychlor sur-
vived for an average of 80.8 weeks (55-104), and
controls for 94.8 weeks (60-104) (Table 1). Fe-
males given methoxychlor survived for 95.4 weeks
(59-104), compared to 96.2 weeks (59-104) for
controls.
C3H male mice receiving methoxychlor sur-
vived for an average of 99.4 weeks (71-104), and
control mice for 101.4 weeks (89-104) (Table 2).
The survival of methoxychlor-treated female mice
did not differ from that of control female mice.
Carcinomas ofthe Testis
Carcinomas of the testis were observed in
BALB/c male mice ingesting methoxychlor, as
well as in a small number of control mice (Table
3). C3H male mice ingesting methoxychlor did
not develop tumors of the testis.
Carcinomas of the testis were present in 27 of
51 BALB/c male mice (53%) ingesting methoxy-
chlor compared to 8 of 71 control male mice (11%)
(p = 0.000,000,6). Tumors of the testis were more
malignant in methoxychlor-treated mice than in
the control mice. They were observed at an earlier
age (an average of 87.5 weeks for treated and
103.8 weeks for controls); were larger in size (car-
cinomas were large in treated mice; whereas
three of the seven carcinomas in controls were 2-4
mm in size); were less differentiated histologi-
cally; and were more invasive in methoxychlor-
treated mice than in control mice. They also occa-
sionally were bilateral in treated mice. One
treated mouse had a metastasis to a lymph node
adjacent to the left adrenal, which was seen
grossly. The incidence of metastases is not re-
liable unless serial sections of lymph nodes and
other organs are examined histologically, which
was not the case in this study.
Neoplasms ofthe Liver
C3H Mice. Male C3H mice ingesting me-
thoxychlor were more susceptible to the develop-
ment of carcinomas of the liver than were female
mice. Carcinomas of the liver were present in 43
of 92 C3H male mice (47%) (p = 0.00088) and 15
of the 83 female mice (18%) ingesting methoxy-
chlor; whereas 23 of 96 control male mice (24%)
and 11 of 99 control female mice (11%) developed
hepatocellular carcinomas (Table 4).
There was occasionally more than one carci-
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Table 1. Survival times for male and female BALB/c mice
ingesting methoxychlor (FDA mouse study).
Survival time, weeks
Males Females
Dose,
ppm Average Range Average Range
0 94.8 60-104 96.2 59-104
750 80.8 55-104 95.4 59-104
noma of the liver measuring 3-5 cm in diameter
in mice given the pesticide in the diet. By con-
trast, the carcinomas in control mice were soli-
tary. There were metastases in the lungs of one
male mouse ingesting methoxychlor and two con-
trol male mice. The reporting of the incidence of
lung metastases is not reliable unless, among
other things, serial sections are done, which was
not the case in this study.
BALB/c Mice. Both BALB/c male and female
mice given methoxychlor were susceptible to
hepatic carcinogenesis. BALB/c male mice devel-
oped more malignant neoplasms of the liver than
female mice. Neoplasms of the liver were ob-
served in 18 of 67 BALB/c male mice (27%) (p =
0.00014) and 12 of 96 female mice (13%) inge-
sting methoxychlor in the diet (p = 0.00745)
(Table 5). There were carcinomas of the liver in 3
of 73 control male (4%) and 2 of 89 control female
mice (2%). The neoplasms in methoxychlor-
treated mice were hepatocellular carcinomas and
hemangiosarcomas of the liver. The number of
neoplasms per liver generally did not differ in
treated and untreated mice. Carcinomas were of-
ten completely necrotic, probably from infarction.
Metastases from neoplasms of the liver to the
lung were not seen in either treated or control
mice.
Neoplasms at all Sites
BALB/c male mice ingesting methoxychlor
were more susceptible to the development of ma-
lignant neoplasms at all sites than were female
mice. Malignant neoplasms were seen in 48 of 67
Table 2. Survival times for male and female C3H mice
ingesting methoxychlor (FDA mouse study).
Survival time, weeks
Males Females
Dose,
ppm Average Range Average Range
0 101.4 89-104 98.0 71-104
750 99.4 71-104 98.5 81-104
Environmental Health PerspectivesTable 3. Number ofBALB/c male mice ingesting
methoxychlor with carcinomas ofthe testis (FDA mouse
study).'
Dose, ppm Carcinomas
0 8/71 (11%)
750 27/51 (53%), p = 0.000,000,6
aCorrected for survival times in this and following tables
BALB/c male (72%) (p < 0.00001) and 45 of 96
female mice (47%) (p = 0.03355) ingesting me-
thoxychlor and 20 of 73 control male (27%) and 29
of 89 control female mice (33%) (Table 6).
The neoplasms were predominantly carcinomas
in treated male and control male mice; whereas
female mice had both carcinomas and sarcomas.
Sarcomas metastasized in 3 male mice (4%) and 4
female mice (4%) given methoxychlor, compared
to 0 in the control mice. Carcinomas in male mice
receiving methoxychlor in the diet developed in
the liver, testis, and lung. Sarcomas of the uterus
and liver were observed in female mice given me-
thoxychlor.
Summary
Methoxychlor is carcinogenic for the liver of
C3H and BALB/c male mice and BALB/c female
mice and for the testis of BALB/c male mice.
There also was an increase in malignant neo-
plasms at all sites in BALB/c male and female
mice. C3H and BALB/c male mice were more sus-
ceptible to the carcinogenic effects of methoxy-
chlor than were female mice. BALB/c mice were
more susceptible than C3H mice.
FDA Methoxychlor Rat Study
Osborne-Mendel strain male and female rats, 21
days of age, 12 per group, were used (4). Litter-
mates were selected at random for the test and
control groups. Rats were housed individually and
were allowed food and water ad libitum. Technical
methoxychlor was dissolved in 1% corn oil and in-
corporated into ground commercial laboratory
meal in a food mixer. Rats ingested dietary levels
Table 4. Number ofC3H male and female mice ingesting
methoxychlor with carcinomas ofthe liver (FDA mouse
study).
Dose,
ppm Males Females
0 23/96 (24%) 11/99 (11%)
750 43/92 (47%), p = 0.00088 15/83 (18%)
of 0, 10, 25, 100, 200, 500, or 2000 ppm for 104
weeks.
Histological sections were made on tumors ob-
served on gross examination, except for a few
"lymphosarcomas." In 19 rats, additional organs
were also examined histologically. Tissues were
sectioned from 22 rats given 2000 ppm, 19 rats
given 500 ppm, 18 rats given 200 ppm, 16 rats
given 100 ppm, 5 rats receiving 25 ppm, 3 rats re-
ceiving 10 ppm methoxychlor, and 16 control rats.
Histological sections from 19 rats included lung,
heart, liver, spleen, pancreas, stomach, small in-
testine, colon, kidney, adrenal, thyroid, testis,
uterus, ovary, leg muscle, leg bone, and bone mar-
row. In the other 80 rats, sections were made of
liver, kidney, and testis.
Neoplasms ofthe Liver in Female Rats
Carcinomas were present in the liver of treated
females. Three of nine female rats (33%) inge-
sting 2000 ppm had carcinomas compared to 0%
control female rats; and an additional rat had a
hyperplastic nodule, which increased the in-
cidence of hepatic neoplasms to 44% in female
rats given 2000 ppm methoxychlor (p = 0.04118)
(Table 7). Ten of 52 treated female rats (19%)
had hyperplastic nodules or carcinomas of the
liver. This incidence is significant when compared
with the usual 1 of 50 neoplasms of the liver ob-
served in control rats in this laboratory (FDA) (p
= 0.00478). All but one of the neoplasms were
found in the survivors.
Female rats ingesting methoxychlor developed
severe diffuse hyperplasia of the liver which gen-
erally was 2-3+ in rats given 25 ppm and in-
creased to 5+ in rats receiving 2000 ppm me-
thoxychlor. Hyperplasia was 0-1+ in control rats.
Table 5. Number ofBALB/c male and female mice ingesting methoxychlor with malignant neoplasms ofthe liver (FDA
mouse study).a
Dose, ppm Males Females
0 3/73 ( 4%) 2/89 ( 2%)
750 18/67 (27%), p = 0.00014 12/96 (13%)pa p = 0.00745
a One male mouse given methoxychlor had hemangiosarcoma of the liver; five female mice receiving methoxychlor developed
hemangiosarcomas of the liver; the other mice had hepatocellular carcinomas.
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mouse study).
Dose, ppm Males Females
0 20/73 (27%) 29/89 (33%)
750 48/67 (72%), p < 0.00001 45/96 (47%), p = 0.03355
Neoplasms ofthe Liver in Male Rats
Carcinomas of the liver were observed in three
of eight male rats (38%) ingesting 2000 ppm me-
thoxychlor and in 0% controls (Table 8). An addi-
tional treated rat had a hyperplastic nodule, in-
creasing the incidence of hepatic neoplasms to
50%. Eight of 32 male rats (25%) given methoxy-
chlor developed hyperplastic nodules and carcino-
mas of the liver; whereas 0% were observed in
control male rats. This incidence is significant
when compared to the usual 1 of 50 neoplasms of
the liver generally observed in this laboratory
(FDA) (p = 0.00189).
Control rats had hyperplasia that was 0-1+, and
treated male rats had severe diffuse hyperplasia
which increased from 2-3+ in rats given 25 ppm
methoxychlor to 5+ in rats given 200, 500, or 2000
ppm.
Carcinomas ofthe Ovary in Female
Rats
Five of 10 female rats (50%) ingesting 500 ppm
and 1 of 10 (10%) given 100 ppm developed carci-
nomas of the ovary. There were small carcinomas
in rats given 500 ppm. The one in the female
given 100 ppm was a large carcinoma, measuring
several centimeters in diameter. When ovarian
tumors are included, the incidence of carcinomas
in female rats given 500 ppm increased from 20%
to 70% (p = 0.0099) and the incidence of malig-
nant tumors to 90% (Table 9). The incidence of
carcinomas of the ovary is significant when com-
pared to 0 of 10 control rats (p = 0.01625) and also
when compared to 0 to 50 observed in control rats
in this laboratory (FDA) (p = 0.00005).
Malignant Neoplasms in Other Organs
Malignant neoplasms present in other organs in
methoxychlor-treated and untreated female rats
were carcinomas of the mammary gland or lym-
phosarcomas, generally of the lung. Lymphosar-
comas also were present in male rats.
Summary and Conclusions
Male and female rats developed significant in-
cidences of hepatocellular carcinomas of the liver.
Carcinomas of the ovary were also significantly
increased in treated female rats. Methoxychlor-
treated male and female rats also had severe dif-
fuse hyperplasia of the liver.
Methoxychlor is carcinogenic for the liver in
male and female Osborne-Mendel rats and for the
ovary of Osborne-Mendel female rats.
FDA Methoxychlor Dog Study
One male and three female dogs were fed 300
mg/kg/day of methoxychlor for 3.5 years (5).
Methoxychlor was given in capsules as a 10% solu-
tion in corn oil.
Two dogs died after 105 and 260 days. One of
those was a female dogthat had tremors after the
beginning and before the end of the treatment.
The cause of death was probably acute pneu-
monia. The second dog, a male, had hemorrhage
Table 7. Numberoffemale rats ingesting methoxychlor with neoplasms ofthe liver (FDA fat study).a
Dose, ppm Hyperplastic nodules Carcinomas Total neoplasms
0 0/9 (0%) 0/9 (0%) 0/9 (0%)
10 1/7 (14%) 0/7 (0%) 1/7 (14%)
25 1/11 ( 9%) 0/11 (0%) 1/11 (9%)
100 1/7 (14%) 0/7 (0%) 1/7 (14%)
200 2/9 (22%) 0/9 (0%) 2/9 (22%)
500 1/9 (11%) 0/9 (0%) 1/9 (11%)
2000 1/9 (11%) 3/9 (33%) 4/9 (44%),p = 0.04118
10-2000 7/52 (13%) 3/52 (6%) 10/52 (19%), p = 0.00478
a Corrected for survival times in this and following tables.
b Ten of 52 versus 1 of 50 (2%) controls with neoplasms of the liver.
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Dose, ppm Hyperplastic nodules Carcinomas Total neoplasms
0 0/4 (0%) 0/4 (0%) 0/4 (0%)
10 0/5 (0%) 0/5 (0%) 0/5 (0%)
25 0/4 (0%) 0/4 (0%) 0/4 (0%)
100 3/7 (43%) 0/7 (0%) 3/7 (23%)
200 0/4 (0%) 0/4 (0%) 0/4 (0%)
500 1/4 (25%) 0/4 (0%) 1/4 (20%)
2000 1/8 (12%o) 3/8 (38%) 4/8 (50%)
10-2000 5/32 (16%) 3/32 (9%) 8/32 (25%), p = 0.00189b
p = 0.0161C
a Corrected for survival time.
b Eight of 32 versus 1 of 50 (2%) controls with neoplasms of the liver.
c Test for positive trend.
in the lung, as well as small hemorrhages else-
where, and increased fat in the liver and adrenal.
The other two female dogs, each about 6 years
old, were killed after receiving methoxychlor for
3.5 years. There were two pale round foci, 6 and 8
mm in diameter, in the left lobe of the liver of one
dog. A whitish nodule, 8 mm in diameter, was
noted in the spleen of the same dog. Tissues of all
organs were examined histologically.
The foci observed on gross examination were
small hepatocellular carcinomas of the liver.
There also was a small number of hepatic cells
with foamy cytoplasm around central veins in the
same dog. In the second dog, which was described
as "negative" grossly, there was "slight fibrosis,
with fibrotic areas containing macrophages with
yellowish pigment, new blood vessels, and small
bile duct-like structures." Fat stains disclosed a
small amount of fat in the livers.
The adrenals in both dogs had slightly bal-
looned cells in the zona fasciculata, in which in-
creased fat was demonstrated. The nodule in the
spleen was lymphoid tissue. There was increased
fat in the outer cortex of the kidney in 1 dog and
chronic cholecystitis in both dogs.
In summary, one female dog given methoxy-
chlor in the diet for 3.5 years developed carcinoma
of the liver; another had fibrosis of the liver.
There also was increased lipid in the adrenal
glands.
FDA Methoxychlor Miniature Male
and Female Swine Study
Twenty-eight miniature swine, 6.5-23.5 months
old were started on a study in which methoxychlor
was added to the feed at a daily dosage level of 1
g/kg body weight (6). The 28 swine were divided
into the following groups: three spayed gilts, four
boars, four sows, and seven gilts bred prior to
test, four sows and four gilts started on test and
then bred (one gilt did not come into heat), one
gilt started on test at the time of farrowing, and
one bred gilt sacrificed as a control.
At periods from 4-12 weeks on test the dosage
level was increased to 2 g/kg body weight in four
sows and three gilts. One control was also given 1
g/kg after she had farrowed.
The three spayed gilts exhibited signs of con-
tinuous heat after 21 days on methoxychlor and 1
also had a prolapsed vagina. Female piglets from
three animals developed swollen vulvas and
showed signs of heat. Eight females started on
test before breeding had moderate hyperplasia of
the mammary gland with milk-like secretion prior
Table 9. Number offemale rats ingesting methoxychlor with malignant neoplasms (FDA rat study).
Dose, ppm Carcinomas Sarcomas Totala
0 1/10 (10%) 1/10 (10%) 2/10 (20%)
10 2/10 (20%) 0/10 (0%) 2/10 (20%)
25 4/11 (36%) 2/11 (18%) 4/11 (36%)
100 3/10 (30%) 1/10 (10%) 4/10 (40%)
200 2/11 (18%) 1/11 (9%) 3/11 (27%)
500 7/10 (70%), p =0.0099 2/10 (20%) 9/10 (90%)
2000 3/11 (27%) 0/11 (0%) 3/11 (27%)
10-2000 21/63 (33%), p = 0.0558b 6/63 10%) 25/63 (32%)
a Rats with carcinoma and sarcoma are counted only once.
b Departure from trend.
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signs of pseudocyesis, one failed to come into
heat, and one conceived and farrowed. Changes
were not observed in the four male swine.
Histological examination was done on brain,
thyroid, liver, pancreas, spleen, kidney, adrenal,
testis, uterus, ovary, and mammary gland. In ad-
dition, the pituitary, heart, lung, thymus, spinal
cord, small intestine, colon, and male accessory
glands were examined from several pigs. Six
testes from castrated boars were used as controls.
Two animals died after periods of 10 and 17
weeks of test. The sow that died after 10 weeks
had severe hemorrhage and necrosis of the gas-
trointestinal tract. The remaining 25 swine given
methoxychlor in the feed were killed at periods
varying from 6-40 weeks.
Lesions Observed on Gross
Examination
Severe fibrotic lesions or scarring of the kid-
neys was seen consistently in all animals given
methoxychlor in the feed. Cysts were present in
the uteri of the three spayed gilts. Two females
that had farrowed and four that did not conceive
had edematous uteri. There were cysts in the me-
sosalpinx or mesovarium in four females. Two of
the four boars had small testes.
Liver changes were described as yellowish and
reticulated in a pregnant sow and as light brown
and hard in a gilt that had farrowed. Ascites was
present in one boar and in one sow that had far-
rowed.
Renal and Hepatic Disease
Chronic interstitial fibrosis was present in all
pigs given methoxychlor. There was extensive
golden brown pigment in the cytoplasm of tubular
epithelial cells in the kidney of 19 of 27 swine
(70%). Special stains characterized the pigment
as lipofuscin.
There was moderate to severe fatty change in
the livers of four females; three of the females
had farrowed and one was killed during preg-
nancy. The hepatic cells varied in size in one fe-
male. Pigment similar to that in the kidney was
observed in the cytoplasm of the hepatic cells of
all animals, and it was marked in 21.
Changes in the Uterus, Mammary
Gland, and Testis
Endometrial hyperplasia was seen in the uteri
of all females given methoxychlor. There was se-
vere mammary gland hyperplasia in 16 female
pigs, including five unspayed, nonpregnent fe-
males. Two spayed gilts had mild hyperplasia. The
testes of one boar did not contain interstitial cells.
Summary
Swine given methoxychlor developed chronic
interstitial fibrosis of the kidney in relatively
short periods of time. There also was hyperplasia
of the mammary gland and uterus, suggesting an
estrogen-like effect on those organs.
FDA Methoxychlor Mature Male
Swine Study
Six mature, castrated, miniature male swine
were started on an experiment in which methoxy-
chlor was mixed in the diet at a level of 1 g/kg
body weight/day (7). Two of the six swine were
fed standard rations and served as controls. One
control and two test animals were sacrificed after
3.5 months on test. The remaining two test ani-
mals were maintained on 1 g/kg for approxi-
mately 4.5 months and then given 2 g/kg for an
additional 26 days before termination of the
study. Histopathological examinations were de-
tailed.
Lesions ofthe Mammary Gland
The teats of all test animals were enlarged af-
ter 2.5 months on test. There appeared to be no
further enlargement of the teats in any of the an-
imals regardless of time on test (up to 5.5
months), or an increase in dose level of methoxy-
chlor. Histopathologically, all test animals showed
a definite development of glandular tissue with
secretory material in the acini in the mammary
glands. No glandular development was noted in
the controls.
Hepatic and Renal Lesions
The kidneys of all test animals showed chronic
interstitial fibrosis, and various amounts of
brownish pigment in the cytoplasm of tubular
cells. The two animals maintained on methoxy-
chlor at levels of 1 g/kg body weight/day for 4.5
months and 2 g/kg for an approximate additional
month showed a fine, granular brownish pigment
in the cytoplasm of hepatic cells.
Summary
Mature castrated male swine given methoxy-
chlor developed pseudopregnancy. Therefore this
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rated female swine as previously shown (6). Age
did not influence the development of chronic renal
disease.
FDA Methoxychlor Immature Male
Swine Study
Four castrated male miniature swine, approxi-
mately 11 weeks of age, were started on an exper-
iment in which methoxychlor was added to the
diet at a level of 2 gm/kg of body weight per day
(8). One male castrate was fed standard ration
and served as a control. All animnals survived and
were sacrificed at the end of the 18-week test pe-
riod. Histopathological examination consisted of
liver, kidney, and mammary gland.
Lesions Observed on Gross
Examination
There was enlargement of the teats and bases
of the teats in all the animals fed methoxychlor.
The kidneys of all test animals showed extensive
pitting and scarring on gross examination. An ab-
scess approximately 1 cm in diameter was present
in the myocardium of the control animal.
Lesions ofthe Kidney, Mammary Gland,
and Liver
Changes in the mammary glands were not as
striking as in the experiment with mature cast-
rated males in which there was definite develop-
ment of secretory acini. Changes in immature
castrated male swine consisted of a slight but def-
inite increase and development of the duct system
with an occasional secretory tubule. There was
hyperplasia of the duct epithelium in all test ani-
mals and squamous metaplasia of the epithelium
in the mammary gland in one. In the mammary
glands of the control swine there were small or
rudimentary ducts.
The livers of two test animals contained small
amounts of a yellowish-brown pigment in the
cytoplasm of hepatic cells. Swine also had chronic
interstitial fibrosis of the kidneys.
Summary
Immature castrated male swine given me-
thoxychlor developed hyperplasia of the ducts of
the mammary gland and chronic renal disease.
FDA Methoxychlor Rabbit Study
Methoxychlor was applied to the skin, 30% in
dimethyl phthalate, of male and female rabbits
(9). The doses were 0.5, 1.0, 2.0, or 4.0 ml/kg/day,
5 days a week, over a 109-day period (78 appli-
cations). There were two males and one female in
each group, with the exception of three male rab-
bits given the 2.0 ml dose. Complete necropsies
were done on male rabbits given the 2.0 or 4.0 ml
doses, except for one given 4.0 ml because of ad-
vanced autolysis. The heart, liver, gallbladder,
kidney, testes, uterus, ovary, skin, and bone mar-
row were examined histologically in the remain-
ing six rabbits. A Giemsa-stained smear of bone
marrow was studied for every rabbit.
Rabbits receiving methoxychlor developed se-
vere anorexia, depression, and emaciation; one
male rabbit receiving 4.0 ml/kg/day was dead af-
ter 10 days and one female died after 28 days. The
following changes were observed in the male rab-
bit: slight atrophy of liver, spleen, muscle and
pancreas; moderate atrophy of skin appendages
and marrow; severe atrophy of testes; edema of
the wall of the gallbladder; slight to moderate hy-
perkeratosis; and slight thickening of the stratus
spinogum of the skin.
One male rabbit given 2.0 ml/kg/day methoxy-
chlor was markedly emaciated and moribund and
was killed after 10 days. The rabbit had moderate
atrophy of the liver, spleen, bone marrow, testes,
and pancreas.
The remaining nine rabbits survived for the du-
ration of the study. The male rabbit given 4.0 ml/
kg/day was markedly emaciated; the rabbits
given the other doses were slightly to moderately
emaciated.
Skin Lesions
The skins of all the surviving rabbits were
slightly rough with a small or moderate amount of
whitish branny scaling. "Hyperkeratosis was
moderate, or slight to moderate; thickening of the
stratum spinosum of the epidermis was either
slight or slight to moderate; infiltration of the
subepidermal corium with chiefly mononuclear
cells varied from almost none to a small amount.
No ulceration of the skin was seen."
Chronic Renal Disease
The male rabbit given 4.0 ml/kg/day methoxy-
chlor had kidneys which were double the normal
size and were slightly pale, fibrous and granular,
and the testes were markedly atrophic. There was
slight portal fibrosis, cellular infiltration and at-
rophy of the liver. The chronic interstitial fibrosis
was severe. One female given 1.0 ml/kg/day and
one male receiving 2.0 ml/kg/day had focal neph-
ritis.
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damaged to a moderate degree; the damage con-
sists of narrow bands or groups of dilated, en-
larged or atrophic tubules mixed with other small
groups or bands of tubules which appear normal
except for perhaps some compensatory hyper-
trophy. Such glomerular atrophy or other glo-
merular damage as is present appears to be sec-
ondary to the tubular damages in the same
locality. Intermingled with the atrophic tubules is
a moderate amount of loose fibrous tissue and a
relatively small amount of chronic inflammatory
cellular exudate" (9).
Atrophy ofthe Testes
Atrophy of the testes was proportional to the
dosage of methoxychlor and was present in all
surviving rabbits (7 of 7 rabbits). The atrophy
was severe in rabbits given 2.0 or 4.0 ml/kg/day,
moderate in those receiving 1.0 ml/kg/day, and
slight in one rabbit at the lowest dose; the re-
maining rabbit at the lowest dose had focal
marked atrophy. There was marked atrophy in
the rabbit receiving the highest dose for only 10
days. Atrophy was not described in the rabbits
given 2.0 ml/kg/day for a 15-day period.
Lesions ofthe Bone Marrow
There was reduction in the number of mature
granulocytes of the bone marrow in a male rabbit
given 2.0 ml/kg/day. The marrow was slightly hy-
perplastic in a male given the highest dose, and
another male receiving 1.0 ml/kg/day. The mar-
row was hyperplastic in one male and one female
at the 0.5 ml dose.
Summary
Methoxychlor applied to the skin over a period
of 109 days caused atrophy of the testes in male
rabbits. The degree of atrophy was related to the
dose, i.e., severe at the two highest doses and
moderate at the lower doses. The one surviving
rabbit receiving the highest dose developed se-
vere chronic interstitial fibrosis of the kidney.
Changes were also observed in the skin and bone
marrow.
NCI Methoxychlor Rat Study
Osborne-Mendel male and female rats, 44 days
of age, were given methoxychlor at two dose lev-
els in the diet (10). There were 50 treated rats in
each group, and 20 control rats of each sex.
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Male rats ingested an average of 442 or 845
ppm for 78 weeks. Female rats ingested an aver-
age of 845 or 1385 ppm (Table 10). Rats were
killed after 111 weeks.
The life span of rats ingesting methoxychlor
was shortened, particularly those receiving the
low dose (Table 11).
Sarcomas in Male Rats
There was an increase in sarcomas in male rats
ingesting methoxychlor (Table 12). Most of the
sarcomas were hemangiosarcomas and they oc-
curred in the spleen and abdomen. There were
more sarcomas of the spleen (19%) in male rats
given the low dose. There were more sarcomas of
the abdomen (10%) in male rats receiving the
high dose or methoxychlor.
Neoplasms ofthe Pituitary
Female rats given the high dose of methoxy-
chlor had over two times as many adenomas and
carcinomas of the pituitary (43%) (p = 0.067)
compared to the controls (20%) (Table 13). The
neoplasms were dose-related (p = 0.038).
Neoplasms ofthe Adrenal Gland
Carcinomas of the adrenal gland, as well as
both adenomas and carcinomas, were increased in
female rats given the low or high doses of me-
thoxychlor (Table 14). Benign and malignant
neoplasms were observed in 15% of the controls,
in 30% of the rats on the low dose, and 38% of the
rats on the high dose.
Neoplasms ofthe Ovary
Carcinomas of the ovary were present in 0 of 20
control female rats (0%), 5 of 46 female rats
(11%) given the low dose, and 11 of 47 female rats
(23%) (p = 0.014) receiving the high dose of me-
thoxychlor (Table 15). Neoplasms of the ovary
were dose-related (p = 0.0034).
Table 10. Dose levels for male and female rats ingesting
methoxychlor (NCI ratstudy).
Males Females
Low High Low High
Initial dose, ppm 360 720 750 1500
Average dose, ppm 442 845 845 1385
Environmental Health PerspectivesTable 11. Survival times for male and female rats ingesting
methoxychlor (NCI rat study).
Survival times, weeks
Males Females
Dose Average Range Average Range
0 106.0 84-111 108.8 94-111
Low dose 101.6 74-111 103.2 76-111
High dose 106.1 25_11ia 106.9 54-111
a One rat had a subcutaneous sarcoma with metastases at 25
weeks.
Neoplasms ofthe Mammary Gland
Carcinomas of the mammary gland were ob-
served in 3 of 20 control female rats (15%), 15 of
46 female rats (33%) ingesting the low dose, and
14 of 47 female rats (30%) given the high dose of
methoxychlor (Table 16).
Neoplasms ofthe Liver
Female rats ingesting the high dose of me-
thoxychlor developed increased incidences of hy-
perplastic nodules and carcinomas of the liver. Of
47 female rats, 21 (45%) had hyperplastic nodules
(p = 0.00010) compared to 0% in the controls
(Table 17). Six of 47 female rats (13%) on the
high dose and 1 of 20 female control rats (5%) had
carcinomas of the liver. Neoplasms of the liver
were seen in 27 of 47 methoxychlor-treated fe-
male rats given the high dose (58%) and 1 of 20
control female rats (5%) (p = 0.00003). Neo-
plasms of the liver were dose related (p = 0.39 x
10-8). In addition, 12 rats given the high dose of
methoxychlor developed moderate or severe dif-
fuse hyperplasia of the liver.
Lesions Other Than Neoplasms
One low dose male rat given methoxychlor had
a thrombus in a hepatic vein. None were seen in
controls.
Comments
This study most likely should be considered an
unsatisfactory study. Many of the rats had only
one to three histological sections, and autolysis
was often advanced (Tables 18 and 19). Further-
more, the incidence of benign and malignant
neoplasms in control rats was so high that differ-
ences between the controls and methoxychlor-
treated rats could not be detected. This high
incidence in control rats strongly suggests
contamination of those rats with methoxychlor.
There were some positive findings despite these
shortcomings.
Hepatic vein thrombi, seen in mice receiving
dieldrin, aldrin, heptachlor, or heptachlor epoxide,
were rarely seen in Osborne-Mendel rats given
dieldrin or aldrin (11, 12).
Summary
Methoxychlor is carcinogenic for the liver and
ovary of female rats. The incidence of sarcomas
of the spleen and abdomen, mostly heman-
giosarcomas, was increased, but not significantly,
in male rats. Neoplasms of the thyroid, pituitary,
adrenals, and mammary gland were also in-
creased in methoxychlor-treated female rats.
NCI Methoxychlor Mouse Study
B6C3F, male and female mice, 41 days of age,
ingested methoxychlor at 2 dose levels in the diet
(10). There were 50 treated mice in each group,
and 20 control mice of each sex.
Female mice ingested 750 or 1500 ppm me-
thoxychlor for 14 days and 1000 or 2000 ppm for
532 days. Male mice received 1400 or 2800 ppm
methoxychlor for 14 days and 1750 or 3500 ppm
for 532 days (Table 20). Mice were killed after 92
weeks.
Some male mice given the low or high dose of
methoxychlor died early, as did some control male
mice (Table 21).
Examinations of male and female mice ingest-
ing methoxychlor, particularly female mice, were
not adequate (Tables 22 and 23). The 19 male
mice on the high dose and 17 male mice on the low
dose of methoxychlor were not examined histolog-
ically, although some may have been examined
grossly. Eleven low dose male mice were dis-
Table 12. Number ofmale rats ingestingmethgxychlor with sarcomas ofthe spleen,abdomen, or subcutaneous tissue (NCI
rat study).a
Subcutaneous
Dose Spleen Abdominal tissue Total
0 1/20 (5%) 0/20 (0%) 2/20 (10%) 3/20 (15%)
Low dose 8/43 (19%) 2/43 (5%) 1/43 (2%) 11/43 (26%)
High dose 4/41 (10%) 0.084b 3/41 (7%) 11/41 (27%)
a Corrected for survival time in this and the following tables.
b Test for positive trend.
November 1980 213Table 13. Number offemale rats ingesting methoxychlor with neoplasms ofthe pituitary (NCI rat study).
Dose Adenomas Carcinomas Total
0 0/20 (0%) 4/20 (20%) 4/20 (20%)
Low dose 7/46 (15%) p = 0.069 8/46 (17%) 15/46 (33%)
High dose 5/49 (10%) 15/47 (32%) 20/47 (43%),p= 0.067
0.038a
a Test for positive trend.
carded because of autolysis. Large numbers of fe-
male mice ingesting methoxychlor were not ex-
amined histologically (30 mice on the low dose
and 35 mice on the high dose).
Neoplasms ofthe Liver
Small numbers of male mice ingesting me-
thoxychlor developed carcinomas of the liver, as
did the control mice. The carcinomas were larger
and more undifferentiated in the methoxychlor-
treated mice than in the control mice.
Neoplasms at All Sites
Of females ingesting the low dose of methoxy-
chlor, 34% (6 of 17) developed malignant neo-
plasms, compared with 1 of 20 (5%) control fe-
male mice (p = 0.0259) (Table 24). Small numbers
of sections of the spleen and lymph nodes showed
hyperplasia and/or early lymphomas.
Hemangiosarcomas ofthe Vertebrae
Hemangiosarcomas of the vertebral bone were
present in 12 of 14 female mice (86%) (p <
0.00001) and 5 of 33 male mice (15%) ingesting
the high dose of methoxychlor, 16 of 16 female
mice (100%) (p < 0.00001) and 2 of 36 male mice
(6%) ingesting the low dose of methoxychlor
(Table 25). By contrast, 0 of 20 control male mice
(0%) and 1 of 17 control female mice (6%) devel-
oped sarcomas of the bone.
Lesions Other Than Neoplasms
Three of 36 male mice (8%) given the low dose
of methoxychlor developed thrombosis of the at-
ria of the heart.
Table 14. Number offemale rats ingesting methoxychlor
with neoplasms ofthe adrenal gland (NCI rat study).
Dose Adenomas Carcinomas Total
0 2/20 (10%) 1/20 (5%) 3/20 (15%)
Low dose 7/46 (15%) 7/46 (15%) 14/46 (30%)
High dose 7/47 (15%) 11/47 (23%) 18/47 (38%)
0.032a
a Test for positive trend.
B6C3F1 male mice, both untreated and treated,
in this laboratory (Hazelton) developed chronic
renal disease and amyloidosis of the kidney and
spleen, as well as liver; whereas they did not in
some other laboratories (Table 26).
Comments
Hemangiosarcomas of the vertebra were strik-
ingly increased in female mice receiving me-
thoxychlor. Such incomplete histopathological ex-
aminations do not make it possible to reach
conclusions concerning the carcinogenicity of me-
thoxychlor for other organs of mice. Neoplasms of
the liver, as well as in other organs, might well be
overlooked. There was, however, a slightly in-
creased incidence of malignant neoplasms in fe-
male mice given the low dose.
The doses of methoxychlor were toxic and killed
many of the mice. The small number of histologi-
cal sections of spleen and lymph nodes suggested
that at least some mice may have developed ma-
lignant lymphomas if they had lived for a long
enough period of time. There also were severe
chronic renal disease, particularly in the male
mice (Table 26).
B6C3F1 female mice given chloroform devel-
oped a significant incidence of thrombosis in the
atria of the heart (13).
C3H mice are more susceptible to the induction
of hepatic neoplasms by the chlorinated hydro-
carbons and should be used rather than B6C3F
(14, 15).
Summary
Methoxychlor is carcinogenic for bone of fe-
male B6C3F1 mice. There was also a significantly
Table 15. Number offemale rats ingesting methoxychlor
with carcinomas ofthe ovary (NCI ratstudy).
Dose Adenomas Carcinomas
0 6/20 (30%) 0/20 (0%)
Low dose 11/46 (24%) 5/46 (11%)
High dose 8/47 (17%) 11/47 (23%),p = 0.014
0.0034a
a Test forpositive trend.
Environmental Health Perspectives 214Table 16. Numberoffemale rats ingesting methoxychlor
with carcinomas ofthe mammary gland.
Dose Female
0 3/20 (15%)
Low dose 15/46 (33%)
High dose 14/47 (30%)
increased incidence of malignant neoplasms at
other sites in female mice ingesting the low dose
of methoxychlor. Methoxychlor was toxic, particu-
larly to female mice, and large numbers were not
Inn ;+nllrhnan rs arln;
x 3 cm in the scapular region. Methoxychlor, 0.10
mg in 0.20 ml of acetone, or methoxychlor, 10 mg
in 0.20 ml of acetone, was applied to the area once
each week. Mice survived for an average time of
342-450 days.
Neoplasms of the skin were not observed in
these mice.
Summary
The oral route should be used for the testing of
methoxychlor for carcinogenicity.
examinieaistLoicualliy DeCaUs oi aUUysis. Methoxychlor
Dog Study of Hodge,
Methoxychlor Mouse Study of Hodge Maynard, and Blanchet
etal.
Male and female mice, 50 of each sex in a group,
of the C3H/Anf strain, were housed on wood
shavings, 12 or 13 to a cage (16). They were 2-4
months old at the beginning of the treatment.
They were given Purina laboratory chow. Me-
thoxychlor was dissolved in trioctanoin (0.05%
and 5.0%).
Mice were examined weekly. They were ob-
served until death, at which time the carcass was
placed in formalin. Gross necropsy was done later
and, if autolysis had not occurred, sections of the
skin were taken for histological study.
Subcutaneous
Single subcutaneous injections of 0.02 ml were
made in the midscapular region. The mean sur-
vival time varied from 372-419 days.
Many mice died with pneumonitis. Neoplasms
were not observed in these mice; however, new-
born or young mice are preferable for single sub-
cutaneous injection studies rather than mice 2-4
months of age.
Skin Painting
Mice were shaved with an electric clipper and
their hair removed from an area approximately 3
Two dogs, sex not given, were each fed 0, 20,
100, or 300 mg/kg/day of methoxychlor for 1 year
(17). One female given 100 mg/kg died after 9
months with severe stomach ulcers. Another fe-
male dog given 20 mg/kg died after 11 months
following an acute illness resembling distemper.
Histological examination was done for heart,
lungs, spleen, stomach, large and small intestine,
liver, adrenal, kidney, bladder, lymph node, bone
marrow, and brain.
Two dogs given 20 mg/kg and the 2 dogs given
300 mg/kg developed hyperplastic lymphoid and
marrow tissue and pyelonephritis and granulomas
of the kidney, as did 1 control dog. The dog given
150 mg/kg/day for 1 year had acute and chronic
cholangitis. One dog receiving 300/mg/kg had
mesenteric adenitis.
Summary
Small numbers of dogs were used in this study
of limited duration. Dogs given methoxychlor did
die and did develop diseases, i.e., cholangitis, mes-
enteric adenitis, and stomach ulcers, which were
not seen in the control dogs.
Methoxychlor Study of Haag et al.
Male and female albino rats about 30 days old
and 7 in each group were used. Rats ingested 0,
Table 17. Neoplasms ofthe liver in female rats ingesting methoxychlor (NCI rat study).
Dose Hyperplastic nodules Carcinomas Total
0 0/20 (0%) 1/20 (5%) 1/20 (5%)
Low dose 2/46 (4%) 1/46 (2%) 3/46 (6%)
High dose 21/47 (45%) p = 0.00010 6/47 (13%) 27/47 (58%) ,a p =0.00003
0.24 x 10-7b 0.39 x 10-8b
0.011C 0.066c 0.001W9
a Twelve additional rats had diffuse hyperplasia of the liver.
b Test for positive trend.
c Departure from trend.
November 1980 215Table 18. Number offemale rats ingesting methoxychlor
with organs studied histologically (NCI rat study).
Organ 0 Low dose High dose
Liver 20 46 47
Kidney 20 32 30
Spleen 20 46 48
Heart 20 32 30
Lungs 20 33 33
Brain 20 32 30
Salivary gland 0 0 0
Pituitary 20 32 36
Adrenal 20 30 31
Thyroid 20 28 31
Ovary 19 30 30
Urinary bladder 20 32 30
Pancreas 20 31 30
Uterus 19 34 35
Bone marrow 20 31 30
Lymph node 20 30 28
Stomach 20 31 31
300, 600, 900, 1200, 2500, 5000, or 10000 ppm of me-
thoxychlor (recrystallized) in ground Purina dog
chow for periods up to 1 year (18).
Histological examinations on selected rats were
done for heart, lungs, gastrointestinal tract, liver,
spleen, kidney, adrenal, pancreas, thyroid, go-
nads, skeletal muscle, and skin. In some cases,
bone marrow and brain were examined. Examina-
tions were done on 7 rats at 1000 ppm, 7 rats at
5000 ppm, 1 at 2500 ppm, and 1 at 600 ppm.
Female rats ingesting 10000 ppm methoxychlor
became emaciated and died within 10 weeks. Male
and female rats given the other doses of methoxy-
chlor survived about as well as the control rats.
Retarded growth was observed in males and fe-
males given 2500 ppm. Lymphosarcomas were
found in 1 rat given 2500 ppm and 1 rat receiving
600 ppm methoxychlor.
Table 19. Number of male rats ingesting methoxychlor
with organs sectioned histologically (NCI rat study).
Organ 0 Low dose High dose
Liver 19 37 37
Kidney 19 21 28
Spleen 20 44 42
Heart 20 21 20
Lungs 20 20 23
Brain 20 19 20
Salivary gland 0 0 2
Pituitary 18 21 22
Adrenal 20 18 19
Thyroid 19 27 24
Testes 15 19 21
Pancreas 19 20 20
Urinary bladder 20 16 21
Bone marrow 20 18 20
Lymph nodes 18 15 17
Stomach 20 20 21
Table 20. Dose levels for male and female mice ingesting
methoxychlor (NCI mouse study).
Males Females
Low High Low High
Initial dose, ppm 1400 2800 750 1500
Average dose, ppm 1746 3941 997 1994
Small numbers of rats were used in this study.
Histological examinations were limited. Results
were not separated by sex.
Methoxychlor Rat Study of
Radomsky et al.
Methoxychlor
Methoxychlor, 80 ppm, was added to Purina lab-
oratory chow supplemented with 1% cod liver oil
(19). The diet was ingested by Osborne-Mendel
weanling male and female rats, 30 in each group,
for 2 years. Control rats were given the diet with-
out the pesticide. All rats which died or were
killed were examined for the presence of tumors.
Tumors were examined histologically.
Treated rats did not have more tumors than the
control rats; however, control rats developed a
high incidence of tumors, particularly mammary
gland. In addition, histological examinations were
incomplete.
Methoxychlor Plus Other Pesticides
A mixture of 50 ppm of each of methoxychlor,
DDT, aramite, and thiourea was ingested by 50
rats of each sex under comparable conditions
(given above). Groups of rats were not given the
individual pesticides by themselves.
Six of 50 control female rats (12%) had hepatic
tumors compared to 9 of 49 female rats (18%)
given the mixture. Tumors of the liver were ob-
served in 1 of 50 male control rats (2%) and 10 of
50 male rats (20%) ingestingthe mixture of pesti-
cides (p = 0.0039).
Another mixture of 80 ppm of each pesticide
Table 21. Survival times for mice ingesting methoxychlor
NCI mouse study).
Survival time, weeks
Males Females
Dose Average Range Average Range
0 72.1 21-92 89.2 80-92
Low dose 73.4 24-92 90.8 71-93
High dose 80.3 34-92 91.8 32-93
Environmental Health Perspectives 216Table 22. Gross and/or histopathology or no examinations
ofmale mice ingesting methoxychlor (NCI mouse study).
Low High
0 dose dose
Initially 20 50 50
Missing 1
Necropsied 12 39 47
Histopathology 12 33 31
Necropsied/no histopathology 6 16
Autolysis/no necropsy 8 11 2
was given to rats. An increase in tumors of the
liver was not noted. Toxicity was not described in
these rats.
Summary
Methoxychlor given with DDT, aramite, and
thiorea is carcinogenic for the liver of male rats.
Untreated female rats developed an unusually
high incidence of neoplasms of the liver. Addi-
tional data are needed in order to draw further
conclusions from this study.
Methoxychlor Rat Study
of Hodge et al.
Male and female rats, 25 per group, ingested 0,
25, 200, or 1600 ppm of methoxychlor in Purina
fox chow meal with meat for two years (17). Sur-
viving rats were killed and necropsied. Histologi-
cal examination was done for heart, lungs, spleen,
stomach, small and large intestine, adrenal, kid-
ney, testes, bladder, bone marrow, and brain, as
well as any abnormal tissues.
Growth was not affected in rats receiving 25 or
200 ppm methoxychlor; however, there was
growth retardation in rats given 1600 ppm. Male
rats had lost 50 g and female rats 20 g at the end
of 1 year. Mortalities of 4-30% occurred in the var-
ious groups during the first year and infection
caused many deaths. There were large numbers
of rats that were unaccounted for in this study.
Four of 11 females (36%) and one of five male
Table 23. Gross and/or histopathology or no examinations
offemale mice ingesting methoxychlor (NCI mouse study).
Low High
0 dose dose
Initially 20 50 50
Missing 1
Necropsied 20 47 50
Histopathology 20 17 15
Necropsied/no histopathology 30 35
Autolysis/no necropsy - 2
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Table 24. Malignant neoplasms at sites otherthan the
vertebrae in female mice ingesting methoxychlor (NCI
mouse study).a
Dose Females
0 1/20 (5%)
Low dose 6/17 (35%), p = 0.0259
High dose 1/15 (7%)
a Only animals that had histological examinations are in-
cluded.
rats (20%) ingesting 1600 ppm, one of seven fe-
male rats (14%) given 200 ppm, and two of ten fe-
male rats (20%) given 25 ppm developed neo-
plasms, whereas zero of eight male and five
female control rats had neoplasms. A total of
seven of 28 female rats (25%) ingesting methoxy-
chlor had neoplasms. There were six surviving
male rats, three receiving 25 ppm and three given
200 ppm methoxychlor, that did not develop neo-
plasms.
The neoplasms in the female rats ingesting
1600 ppm methoxychlor were cystadenoma of the
ovary, neoplasms of the abdominal wall, adeno-
carcinoma of the pancreas, and epidermoid carci-
noma. There was a mammary neoplasm in a fe-
male rat given 200 ppm and neurofibroma and
lung neoplasms in the female rats receiving 25
ppm. One male rat given 1600 ppm had a mam-
mary tumor.
The authors stated that: "One of the most fre-
quent causes of death during the second year in
our rats is cancer. The large number of tumors in
the 0.16% group of females is believed to be
coincidental." However, the data concerning neo-
plasms developing in rats in this study during the
second year were not given.
The results of the study suggest that methoxy-
chlor is carcinogenic, particularly for female rats.
An unusual neoplasm, adenocarcinoma of the pan-
creas, was present in a treated female rat. Since
additional data concerning all rats that died or
were killed before the end of two years is unavail-
able, conclusions cannot be made from this study.
Table 25. Hemangiosarcomas ofthe vertebrae in male and
female mice ingesting methoxychlor (NCI mouse study).
Dose Males Females
0 0/20 (0%) 1/17 (6%)
Low dose 2/36 (6%) 16/16 (100%), p <0.00001
High dose 5/33 (15%) 12/14 (86%), p <0.00001
0.03132a 0.18 x 10-7a
0.0002b
a Test for positive trend.
b Departure from trend.
217Table 26. Number ofmale mice ingestingmethoxychlor
with chronic renal disease and amyloidosis ofthe spleen and
kidney (NCI mouse study).a
Amyloidosis
Chronic renal
Dose disease Spleen Kidney
0 4/12 (33%) 4/12 (33%) 1/12 (8%)
Low dose 10/36 (33%) 9/36 (25%) 4/36 (11%)
High dose 1/33 (3%) 2/33 (6%) 0/33 (0%)
a These data are not reliable because many of the kidneys
and spleens were not examined histologically.
Methoxychlor Rat Study of
Deichmann et al.
Osborne-Mendel male and female rats, 30 per
group, were used. Rats ingested 0 or 1000 ppm
methoxychlor (recrystallized) in ground Purina
laboratory chow for 27 months (20).
The liver, heart, lung, brain, pituitary, kidney,
spleen, pancreas, stomach, small intestine, and
testes or ovary, as well as all tumors, were exam-
ined histologically.
The weight of the rats ingesting methoxychlor
remained the same duringthe second year. At the
end of 24 months, 43% of the male rats and 37% of
the female rats given methoxychlor were living
compared to 50% and 60% of the control rats.
Five of 28 male rats (18%) ingesting methoxy-
chlor developed neoplasms, compared to 1 of 28
control male rats (4%). Data concerning the loca-
tion or the number of malignant neoplasms are
not given for these rats. Many of the neoplasms
in female rats were mammary gland.
There was hydropic change, fatty change, and
focal centrolobular necrosis in the liver and hemo-
siderin in the spleen of methoxychlor-treated
rats.
There was an increased incidence of neoplasms
in male rats ingesting methoxychlor; however, the
data given are incomplete and conclusions cannot
be made concerning the effects of methoxychlor.
Comments
BALB/c strain male mice ingesting methoxy-
chlor developed a highly significant incidence of
interstitial cell carcinomas of the testes. Since
BALB/c strain male mice treated with estrogens
readily develop carcinomas of the testis, the carci-
nogenicity of methoxychlor for testis is most
likely related to its estrogenic activity (2). Meth-
oxychlor was estrogenic for the mammary gland
and uterus in swine in the FDA studies (6-8).
The estrogenic activity of methoxychlor, DDT,
and other analogs has been established. There are
some structural similarities between these com-
pounds and diethylstilbestrol (21). Technical me-
thoxychlor stimulated uterine growth in mice and
rats (22); caused atrophy and abnormal develop-
ment of the testis of young male-rats (23,24); in-
terfered with reproduction in rats (25); and inter-
fered with the in vivo uptake of estradiol by the
rat uterus (26, 27).
DDT, the structural analog of methoxychlor, is
carcinogenic for the liver of mice and rats and for
the ovary of rats (28-35).
The formation and occurrence of tumors in all
mammals is quite similar. Virtually every chem-
ical which has been found to be carcinogenic in
humans is also carcinogenic in one or more other
mammalian test animals (36). It has been demon-
strated that if a chemical will produce neoplasms
in any one species, it will likely produce neo-
plasms in another. We strongly feel that a finding
of carcinogenicity in one mammalian species is
therefore relevant to all mammals, including hu-
mans. This threat may not be manifested for up
to 30 or 40 years, given the long latent period of
many known human carcinogens. Given the state
of carcinogenicity testing and knowledge, there
can be only one safe tolerance for a carcinogen-
an absolute zero tolerance-and the only way a
substance shown to be carcinogenic in test ani-
mals will not be a threat to human health is sim-
ply to prevent that substance from entering the
environment. To the extent that it does enter
man's environment, it will constitute a very real
threat to his health.
The carcinogenicity of methoxychlor was re-
viewed at the IARC. They concluded that "the
available data did not provide evidence that me-
thoxychlor is carcinogenic in animals."
Interpretation of carcinogenicity studies varies
with the reviewer. Problems are often found with
the incomplete presentation and analysis of the
data, as well as with different diagnoses by pa-
thologists (37). The IARC monograph did not in-
clude the FDA mouse and rat studies on methoxy-
chlor because "...., only reports that have been
published or accepted for publication are re-
viewed by the working groups, ...." (38).
The statistical analyses, one sided P (probability) values, were
done by C. W. Riggs, Frederick Cancer Research Center,
Frederick, Maryland, 21701. The NCI methoxychlor rat and
mouse studies were performed under contract at Hazleton
Laboratories, Inc.
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